Quadrature Capital »

Inhibikase Therapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $61k 36k 1.68

More positions owned by Quadrature Capital

Asml Hldg Nv N Y Registry Shs (ASML)
UnitedHealth (UNH)
Spdr Gold Tr Gold Shs (GLD)
Sap Se Spon Adr (SAP)
Micron Technology (MU)
Sandisk Corp (SNDK)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Circle Internet Group Com Cl A (CRCL)
Crowdstrike Hldgs Cl A (CRWD)
Intel Corporation (INTC)
Toronto Dominion Bk Ont Com New (TD)
Select Sector Spdr Tr State Street Ene (XLE)

View all positions for Quadrature Capital

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Trails Edge Capital Partners
ADAR1 Capital Management
BlackRock
Blackstone Group
Siren
Commodore Capital
Vanguard Capital Management
Saturn V Capital Management
Kalehua Capital Management
Squadron Capital Management
Millennium Management
Nantahala Capital Management

View all funds holding Inhibikase Therapeutics